These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34729114)

  • 21. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
    PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
    Stiasny A; Kuhn C; Mayr D; Alexiou C; Janko C; Wiest I; Jeschke U; Kost B
    Anticancer Res; 2016 Jun; 36(6):3195-8. PubMed ID: 27272848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum HPV16 E7 Oncoprotein Is a Recurrence Marker of Oropharyngeal Squamous Cell Carcinomas.
    Oton-Gonzalez L; Rotondo JC; Lanzillotti C; Mazzoni E; Bononi I; Iaquinta MR; Cerritelli L; Malagutti N; Ciorba A; Bianchini C; Pelucchi S; Tognon M; Martini F
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and polyclonal antibody preparation of HPV-11E7 protein].
    Ding Y; Jiang S; Chen X; Chen L; Zhang X; Cheng H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):618-22. PubMed ID: 24909284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody.
    Faoro V; Barbazza R; Bonin S; Brunetti D; Sulfaro S; Stanta G
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):341-50. PubMed ID: 22935825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.
    Heller C; Weisser T; Mueller-Schickert A; Rufer E; Hoh A; Leonhardt RM; Knittler MR
    J Biol Chem; 2011 Apr; 286(13):10983-97. PubMed ID: 21321113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
    Wang HY; Kim G; Cho H; Kim S; Lee D; Park S; Park KH; Lee H
    Exp Mol Pathol; 2015 Jun; 98(3):510-6. PubMed ID: 25835783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between the human papillomavirus 16 E7 oncoprotein and gelsolin ignites cancer cell motility and invasiveness.
    Matarrese P; Abbruzzese C; Mileo AM; Vona R; Ascione B; Visca P; Rollo F; Benevolo M; Malorni W; Paggi MG
    Oncotarget; 2016 Aug; 7(32):50972-50985. PubMed ID: 27072581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population.
    Zhou Z; Yang H; Yang L; Yao Y; Dai S; Shi L; Li C; Yang L; Yan Z; Yao Y
    Infect Genet Evol; 2019 Sep; 73():13-20. PubMed ID: 30981880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK; Cheng SC; Sin FW; Xie Y
    Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical detection of HPV16 E7 in cervical smear.
    Jeon JH; Shin DM; Cho SY; Song KY; Park NH; Kang HS; Kim YD; Kim IG
    Exp Mol Med; 2007 Oct; 39(5):621-8. PubMed ID: 18059138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
    Park S; Park JW; Pitot HC; Lambert PF
    mBio; 2016 May; 7(3):. PubMed ID: 27190216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.
    van der Burg SH; Ressing ME; Kwappenberg KM; de Jong A; Straathof K; de Jong J; Geluk A; van Meijgaarden KE; Franken KL; Ottenhoff TH; Fleuren GJ; Kenter G; Melief CJ; Offringa R
    Int J Cancer; 2001 Mar; 91(5):612-8. PubMed ID: 11267969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of affibody molecules specific for HPV16 E7 recognition.
    Xue X; Wang B; Du W; Zhang C; Song Y; Cai Y; Cen D; Wang L; Xiong Y; Jiang P; Zhu S; Zhao KN; Zhang L
    Oncotarget; 2016 Nov; 7(45):73995-74005. PubMed ID: 27659535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
    Li YL; Qiu XH; Shen C; Liu JN; Zhang J
    Oncol Rep; 2010 Nov; 24(5):1323-9. PubMed ID: 20878127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.
    Donà MG; Giorgi C; Accardi L
    BMC Cancer; 2007 Jan; 7():25. PubMed ID: 17266749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy.
    Zhu D; Shen H; Tan S; Hu Z; Wang L; Yu L; Tian X; Ding W; Ren C; Gao C; Cheng J; Deng M; Liu R; Hu J; Xi L; Wu P; Zhang Z; Ma D; Wang H
    Mol Ther; 2018 Oct; 26(10):2443-2455. PubMed ID: 30241742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.